TokyoTokyo Mon - Fri 10:00-18:00 +81 (366) 701-751
info@mountequitygroup.com

Blog

‘CryptoPunk’ NFT sells for $11.8 million at Sotheby’s

Who says the NFT bubble has popped?  

A non-fungible token (NFT) of a digital artwork called a CryptoPunk defied expectations and just sold for $11.8 million at Sotheby’s on Thursday.

“CryptoPunks are a set of 10,000 pixel-art characters made by Larva Labs in 2017” and the mega bucks one that sold— CryptoPunk #7523 — is “of the sought-after Alien variety with blue-green skin, and wearing a medical mask,” according to Reuters. It was bought with bitcoin and no physical artwork changes hands.

Sotheby’s announced the work was bought by Israeli entrepreneur Shalom Meckenzie, the largest shareholder of digital sports company DraftKings.

“We are excited to continue to explore new and interesting ways in presenting these cutting-edge works,” Michael Bouhanna, a contemporary art specialist at Sotheby’s, told Reuters.

The work was bought by Israeli entrepreneur Shalom Meckenzie, the largest shareholder of digital sports company DraftKings.Sotheby’s/Handout via REUTERS

This week the famous “Doge” NFT also sold at another auction for $4 million.

5 Signs Bitcoin May Be About to Trend Higher

InvestorPlace – Stock Market News, Stock Advice & Trading Tips

Bitcoin (CCC:BTC-USD) is the first, biggest and most important cryptocurrency, so its 40%+ drop the last couple of months as gotten a lot of attention.
Source: Shutterstock
There are the “I told you so” folks who says it’s all falling apart, just like they knew it would all along.
Yeah, right.
Then there are the people who actually study and follow Bitcoin and altcoins, and the entire cryptocurrency industry. They know the transformative power of blockchain.

Think of Bitcoin like the S&P 500 or Wilshire 5000 stock market indexes that give you the best picture of the market as whole. Then, think of altcoins as smaller stocks with more potential.
The transformative technology that is blockchain will take time to move us forward and change everything it can. Smart crypto investors are in it for the long term.
At the same time, everyone wants to know if and when Bitcoin will start moving higher again.
Let’s talk about that. We see several indications that the selling in bitcoin may be about to end … and that’s when we expect it to resume its march toward $100,000.
Here are six indicators flashing good news right now…

Bitcoin’s trading range: Since the massive drop on May 19, Bitcoin has been stuck in a range between $31,000 and $40,000. It has been a relatively stable trading range, with Bitcoin moving from the bottom of the range to the middle this week.
If Bitcoin were to break below $31,000, I expect the drop would be short-lived and that buyers would come in heavily in the mid-$20,000s.
If Bitcoin breaks about $41,000, it could be off and running. And whether that happens now or we need to wait a little longer, altcoins should outperform Bitcoin along the way.
Selling volume is diminishing: The only reason investors move bitcoins to an exchange is to sell them, so we can gain important insight looking at the total number of coins transferred to exchanges. The good news is this total transfer volume is now relatively low.

The amount of Bitcoin transferred to exchanges peaked on May 19. As panic selling set in, more than 166,000 bitcoins were transferred. Other big transfer days included May 13 (about 100,000 coins) and May 17 (about 107,000). This indicated a lot of selling pressure, and the price action reflected this. There simply weren’t enough buyers to absorb this increase in exchange supply.
At the beginning of this week, only about 40,000 coins were moved onto exchanges — about half as much as the big selloff days. That’s a bullish signal … the equivalent of selling volume dropping in the stock market.
Fewer leveraged liquidations: We see a strong link between the massive selloffs on May 12 and 19 to high open interest in futures and leverage. As the price dropped, investors rapidly sold these leveraged positions, putting more downward pressure on the price.
But over the last 21 days, forced sales in the futures markets have stabilized, and total liquidations have dropped to low levels. Open interest in Bitcoin futures has also dropped significantly.
Once Bitcoin breaks out from its trading range, futures open interest will probably increase rapidly. But in that case, it should help drive the price higher as short-term traders make bets based on the strength of the breakout.

Money on the sidelines: With stocks, analysts watch the amount of cash in money market accounts because that is basically money on the “sidelines” ready to be invested. With bitcoins and cryptocurrencies, we look at the amount in stablecoins, which are tied to the U.S. dollar and are basically crypto money market accounts.
In particular, we look at the stablecoin supply ratio, or SSR. This is the ratio between Bitcoin supply and the supply of stablecoins denoted in BTC. When the SSR is low, there are more stablecoins relative to Bitcoin … meaning more Bitcoin “buying power.” That’s exactly what we have right now with the SSR at its lowest levels of 2021.
This tells us that there is a lot of money on the sidelines ready to be redeployed into crypto specifically. All of this “dry powder” on the sidelines can act as a significant catalyst once we see a breakout.
Fear and greed: All investing markets act emotionally, and that’s especially true with cryptos. It’s just human nature to get greedy when prices are going up, which results in FOMO, or “fear of missing out.” Conversely, people tend to react with just plain fear in the face of falling prices, so they tend to sell.

This behavior can be quantified in the Fear and Greed Index. This is the heart of contrarian indicators, and we are big fans. Extreme fear means investors are overly worried and willing to part with their cryptos at really low prices — which means buying opportunities. Extreme greed means a correction is due.
The Byte Fear and Greed Index takes six measurements into account — volatility, market momentum, social media, surveys, market capitalization dominance and trends. Data from all these categories are crunched together to measure market sentiment. A score of 0 would indicate extreme fear while 100 means extreme greed.
So where’s the reading now? All the way down to 13!
This confirms what we already know — there is a lot of fear in the crypto market right now. But it won’t stay that low. The transformation and trend are too powerful, which means these unusually low prices are a great buying opportunity in bitcoin and the strongest altcoins that we expect to surge a lot higher over time.
In the big picture, Bitcoin remains in outstanding shape even with the recent selloff that amounts to nothing more than a speed bump on the road to higher prices.

That is even truer for altcoins. When Bitcoin gets volatile, that volatility is often magnified in the altcoin markets. But the opposite is also true. That’s where we see the big money being made over time.
On the date of publication, Matthew McCall did not have (either directly or indirectly) any positions in the securities mentioned in this article. 
Matthew McCall left Wall Street to actually help investors — by getting them into the world’s biggest, most revolutionary trends BEFORE anyone else. Click here to see what Matt has up his sleeve now.
More From InvestorPlace

The post 5 Signs Bitcoin May Be About to Trend Higher appeared first on InvestorPlace.

Cramer Gives His Opinion On Nvidia, Spotify And More

On CNBC’s “Mad Money Lightning Round,” Jim Cramer said Restoration Hardware Holdings (NYSE:RH) is just getting started and it goes higher.

Moody’s Corporation (NYSE:MCO) is a buy, said Cramer. He likes S&P Global Inc (NYSE:SPGI) better.

Cramer would hold NVIDIA Corporation (NASDAQ:NVDA) and he would buy more if it drops below $700.

Never bet against Eric Grubman, said Cramer. He is a buyer of his SPAC, Sports Entertainment Acquisition Corp (NYSE:SEAH).

ChargePoint Holdings Inc (NYSE:CHPT) is very good, but it has three other competitors Cramer analyzed. With that much competition, he feels it’s difficult to own the stock.

At these levels, you want to buy Spotify Technology SA (NYSE:SPOT), said Cramer.

Remote workers put in longer hours but were less efficient, study says

Employees are beginning to trickle back into their offices just in time — after a new study found that remote work reduces productivity.

The study, which surveyed the remote work habits of 10,000 employees at an Asian technology company between April 2019 and August 2020, found a 20 percent decrease in output, according to a recent report.

Although the workers in “Work from home & productivity: evidence from personnel & analytics data on IT professionals”, by Michael Gibbs, Friederike Mengel and Christoph Siemroth seemed to work longer hours, they were not as efficient as they would be in a structured workplace.

The study found that although the workers spent 30 percent more time working from home, their productivity fell as they spent more time in meetings with their bosses to constantly outline their responsibilities.

The academics also pointed out that the staff at the unnamed firm they studied were involved in particularly challenging work that might be better suited to an office environment. Employees in less-skilled occupations, such as making customer calls, might be better suited to remote situations, the study said.

The subjects of the study were highly trained and their work involved “significant cognitive work, developing new software or hardware applications or solutions, collaborating with teams of professionals, working with clients, and engaging in innovation and continuous improvement.”

Freshpet Voluntarily Recalls One Lot of Freshpet® Select Small Dog Bite Size Beef & Egg Recipe Dog Food Due to Potential Salmonella Contamination

BETHLEHAM, Pa., June 12, 2021 /PRNewswire/ — Freshpet Inc. is announcing a voluntary recall of a single lot of Freshpet® Select Small Dog Bite Size Beef & Egg Recipe Dog Food(1 LB bags), with Sell by Date 10/30/2021, due to potential contamination with Salmonella. Our Freshpet Team had designated this single lot for destruction, but it was inadvertently shipped to retailers in limited geographic markets between June 7 and June 10, 2021.  No other Freshpet products or lot codes are impacted by this recall. Salmonella can affect animals eating the product and there is risk to humans from handling contaminated products, especially if they have not thoroughly washed their hands after having contact with the products or any surfaces exposed to these products.Healthy people infected with Salmonella should monitor themselves for some or all of the following symptoms: nausea, vomiting, diarrhea or bloody diarrhea, abdominal cramping and fever. Rarely, Salmonella can result in more serious ailments, including arterial infections, endocarditis, arthritis, muscle pain, eye irritation, and urinary tract symptoms. Consumers exhibiting these signs after having contact with this product should contact their healthcare providers.Dogs with Salmonella infections may be lethargic and have diarrhea or bloody diarrhea, fever, and vomiting. Some dogs will have only decreased appetite, fever and abdominal pain. Infected but otherwise healthy dogs can be carriers and infect other animals or humans. If your dog has consumed the recalled product and has these symptoms, please contact your veterinarian.

Freshpet has received no reports of illness, injury, or adverse reaction to date, and has issued this recall because of our deep commitment to the safety of our pet parents and their dogs. The limited number of impacted products may have been sold at:  Publix in Florida, South Carolina, and Georgia, and at limited Target locations in Arizona and Southern California. Most of the product was intercepted at retailer distribution warehouses and not delivered to retail stores. If pet parents have products matching the following description in their possession, they should stop feeding it to their dogs and dispose of it immediately.  Please call us if you have any of the recalled product, Freshpet® Select Small Dog Bite Size Beef & Egg Recipe Dog Food(1 LB bags), with Sell by Date 10/30/2021, for a refund or for your convenience you may use the following link to request a refund:  https://freshpet.co/ssdb21.  Sell by Date, along with UPC code and lot code, can be found on the bottom and back of each bag.  Please see chart and product pictures for details.Product NameRetail UPC CodeLot Code

Sell by DateFRESHPET® SELECT SMALL DOG BITE SIZE BEEF & EGG RECIPE6279750129391421FBP010110/30/2021 L2

The safety of pets, pet parents and the quality of our products are of the greatest importance and we value the trust placed in Freshpet.Pet parents who have questions or would like to report adverse reactions should call 1.866.789.3737, Mon. through Fri., 9 am–9 pm (EDT) and Sat. through Sun. 9 am–1 pm (EDT) or visit www.freshpet.com.This recall is being conducted in cooperation with the U.S. Food and Drug Administration.

View original content to download multimedia:https://www.prnewswire.com/news-releases/freshpet-voluntarily-recalls-one-lot-of-freshpet-select-small-dog-bite-size-beef–egg-recipe-dog-food-due-to-potential-salmonella-contamination-301311252.htmlSOURCE Freshpet

Alzheimer's Association Statement: Next Steps For New Alzheimer's Treatment

CHICAGO, June 12, 2021 /PRNewswire/ — As the global nonprofit leader in Alzheimer’s research and science we have extensively reviewed the clinical trial data for Aduhelm™ (aducanumab). Based on the trial data, the treatment demonstrated an efficacious result which has also been confirmed by leading scientists in the Alzheimer’s and dementia scientific community and the Food and Drug Administration (FDA). Alzheimer’s Association’s research experts and advisors are deeply familiar with the basic and regulatory science that led to the FDA’s decision. They were right to approve this treatment. Additionally, the FDA appropriately took into account the vast unmet need of the Alzheimer’s community. Aduhelm is certainly not a cure, but at long last it provides many with Alzheimer’s disease and their families an effective treatment. The confirmatory trial should begin promptly.Our focus has and will continue to be access to this treatment for all likely to benefit. Approval is the fundamental first step to access. The first drug in a category invigorates the field, increases investments in new treatments and encourages greater innovation.Following approval, the manufacturer, Biogen, announced their intention to price Aduhelm at $56,000 per year. This price is simply unacceptable. For many, this price will pose an insurmountable barrier to access, it complicates and jeopardizes sustainable access to this treatment, and may further deepen issues of health equity. We call on Biogen to change this price.

Next, the path to access turns to the Centers for Medicare & Medicaid Services (CMS). Just as with the FDA, we have the utmost respect for CMS and how they will approach the key decisions ahead. We’re committed to working with them — and with the private payer community — to expedite access for all of those who would likely benefit based on the successful clinical trial. CMS faces difficult policy decisions on how to best accomplish this within the context of the Medicare program, and we stand ready to fully support CMS and private payers in this work for all communities in need. Alzheimer’s AssociationThe Alzheimer’s Association leads the way to end Alzheimer’s and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer’s and all other dementia®. For more information, visit www.alz.org or call the 24/7 Helpline at 800.272.3900. View original content to download multimedia:https://www.prnewswire.com/news-releases/alzheimers-association-statement-next-steps-for-new-alzheimers-treatment-301311251.htmlSOURCE Alzheimer’s Association

Sorrento Gets UK Authorization To Conduct Phase 2 Trial For COVI-DROPS; Shares Up

(RTTNews) – Sorrento Therapeutics Inc.(SRNE) announced that the United Kingdom’s regulatory agency has cleared Sorrento’s COVI-DROPS product candidate for a Phase 2 efficacy trial.

The shares of Sorrento Therapeutics rose 5.07% after hours to $9.32 after the Medicines and Healthcare products Regulatory Agency (MHRA) cleared a Phase 2 study for COVID-19 nasal drops in newly diagnosed Covid-19 patients.

The Phase 2 efficacy trial of COVI-DROPS is a large double-blind clinical trial enrolling 350 outpatients with COVID-19 who are either asymptomatic or have mild symptoms compared with a placebo.

The company noted that this trial will complement trials in the U.S. and a separate trial in Mexico.

The COVI-DROPS is administered by intranasal drops and the antibody is active against the original SARS-CoV-2 virus, as well as the UK/Alpha and India/Delta variants, currently prevalent in the UK and US.

The results of this Phase 2 trial in the UK will be combined with the results of the US and Mexico Phase 2 trials and should the results of these studies demonstrate that COVI-DROPS is both safe and effective against SARS-CoV-2, Sorrento will apply for Emergency Use Authorization in the US, India, UK, Mexico and European Union as well as other territories.

Gentleman's Guru – Paving the Way for the Next Generation of Men's Formalwear

LAS VEGAS, June 12, 2021 /PRNewswire/ — Gentleman’s Guru is pleased to present their latest range of luxury formal wear and accessories exclusively for men. The collection currently featured is for the upcoming wedding season as well as for those gentlemen wishing to dress stylishly for parties and events.From classic solid suits to luxury and exotic wedding tuxedos, Gentleman`s Guru offers everything that a man would need to look dashing at his next event. Whether for the groom, the groomsmen, the father of the bride, or the guests, this store is the premium location to purchase your formal attire.Shopping online for formalwear at Gentleman’s Guru provides the utmost convenience and gives its customers a sense of adventure in finding the ultimate wedding tuxedo. You will have peace of mind knowing that you are dealing with professionals that are dedicated to making you look your best on your special day.Headquartered in the glamorous Las Vegas, Gentleman’s Guru provides a wide variety of formalwear and wedding attire while providing the highest level of personalized online expertise that can assist you with your style needs and requirements. Although Gentleman’s Guru excels in premier online-only formal wear, there’s a sense of community with respect to the specifications of each customer that represents everything that a one-on-one customizable encounter would offer. Grooms looking for fashion-forward style and personalized service need to look no farther than Gentleman`s Guru.Contact:

Gentleman’s Guru6865 Speedway Blvd. Suite Q-105, Las Vegas, Nevada 89115Phone: 702-875-6332Email: Support@gentlemansguru.comWebsite: https://www.gentlemansguru.com/

Related Imagesmens-wedding-suits-tuxedos-from.png Men’s Wedding Suits & Tuxedos from Gentlemansguru.comTake your wardrobe to the next level and turn some heads at your next wedding event with Gentleman’s Guru new selection of wedding suits and tuxedos. View original content to download multimedia:https://www.prnewswire.com/news-releases/gentlemans-guru—paving-the-way-for-the-next-generation-of-mens-formalwear-301311204.htmlSOURCE Gentleman’s Guru